ZYMERON
LIVE

Serial Number

88257580

Owner

Zymeron Corporation

Attorney

Steven J. Hultquist

First Use Date

Jan 6, 2016

Filing Date

Jan 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ZYMERON Trademark

Serial Number: 88257580 • Registration: 5813236

ZYMERON is a trademark filed by Zymeron Corporation on January 10, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Zymeron Corporation

PO Box 12072
Durham, NC 27709

Entity Type: 03

Trademark Details

Filing Date

January 10, 2019

Registration Date

July 23, 2019

First Use Anywhere

January 6, 2016

First Use in Commerce

January 6, 2016

Published for Opposition

May 7, 2019

Goods & Services

Product research and development; scientific research and development; biochemical research and development; pharmaceutical research and development; research and development of new products; research and development of new products for others; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibodies; research and development of new products for third parties in the fields of plastic materials; research and development of technology and products in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic sciences, laboratory testing, diagnostics, and pharmacogenetics; consulting services in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; research and development in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; design, engineering, research, development, and testing services in the field of polymeric materials, polymers synthesis, and materials customization for medical, scientific, and technological applications

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 9, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 9, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 6, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 3, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 23, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2019 CNSA
ASSIGNED TO EXAMINER
Mar 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 1, 2019 NWOS
NEW APPLICATION ENTERED
Jan 14, 2019 NWAP